Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process.
Recent laws may not yet be included in the ILCS database, but they are found on this site as
Public
Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the
Guide.
Because the statute database is maintained primarily for legislative drafting purposes,
statutory changes are sometimes included in the statute database before they take effect.
If the source note at the end of a Section of the statutes includes a Public Act that has
not yet taken effect, the version of the law that is currently in effect may have already
been removed from the database and you should refer to that Public Act to see the changes
made to the current law.
(225 ILCS 85/9.6) Sec. 9.6. Administration of vaccines and therapeutics by registered pharmacy technicians and student pharmacists. (a) Under the supervision of an appropriately trained pharmacist, a registered pharmacy technician or student pharmacist may administer COVID-19, SARS-CoV-2, respiratory syncytial virus, and influenza vaccines subcutaneously, intramuscularly, or orally as authorized, approved, or licensed by the United States Food and Drug Administration, subject to the following conditions: (1) the vaccination must be ordered by the |
|
(2) the supervising pharmacist must be readily and
|
| immediately available to the immunizing pharmacy technician or student pharmacist;
|
|
(3) the pharmacy technician or student pharmacist
|
| must complete a practical training program that is approved by the Accreditation Council for Pharmacy Education and that includes hands-on injection technique training and training in the recognition and treatment of emergency reactions to vaccines;
|
|
(4) the pharmacy technician or student pharmacist
|
| must have a current certificate in basic cardiopulmonary resuscitation;
|
|
(5) the pharmacy technician or student pharmacist
|
| must complete, during the relevant licensing period, a minimum of 2 hours of immunization-related continuing pharmacy education that is approved by the Accreditation Council for Pharmacy Education;
|
|
(6) the supervising pharmacist must comply with all
|
| relevant recordkeeping and reporting requirements;
|
|
(7) the supervising pharmacist must be responsible
|
| for complying with requirements related to reporting adverse events;
|
|
(8) the supervising pharmacist must review the
|
| vaccine registry or other vaccination records prior to ordering the vaccination to be administered by the pharmacy technician or student pharmacist;
|
|
(9) the pharmacy technician or student pharmacist
|
| must, if the patient is 18 years of age or younger, inform the patient and the adult caregiver accompanying the patient of the importance of a well-child visit with a pediatrician or other licensed primary-care provider and must refer patients as appropriate;
|
|
(10) in the case of a COVID-19 vaccine, the
|
| vaccination must be ordered and administered according to the Advisory Committee on Immunization Practices' COVID-19 vaccine recommendations;
|
|
(11) in the case of a COVID-19 vaccine, the
|
| supervising pharmacist must comply with any applicable requirements or conditions of use as set forth in the Centers for Disease Control and Prevention COVID-19 vaccination provider agreement and any other federal requirements that apply to the administration of COVID-19 vaccines being administered; and
|
|
(12) the registered pharmacy technician or student
|
| pharmacist and the supervising pharmacist must comply with all other requirements of this Act and the rules adopted thereunder pertaining to the administration of drugs.
|
|
(b) Under the supervision of an appropriately trained pharmacist, a registered pharmacy technician or student pharmacist may administer COVID-19 therapeutics subcutaneously, intramuscularly, or orally as authorized, approved, or licensed by the United States Food and Drug Administration, subject to the following conditions:
(1) the COVID-19 therapeutic must be authorized,
|
| approved or licensed by the United States Food and Drug Administration;
|
|
(2) the COVID-19 therapeutic must be administered
|
| subcutaneously, intramuscularly, or orally in accordance with the United States Food and Drug Administration approval, authorization, or licensing;
|
|
(3) a pharmacy technician or student pharmacist
|
| practicing pursuant to this Section must complete a practical training program that is approved by the Accreditation Council for Pharmacy Education and that includes hands-on injection technique training, clinical evaluation of indications and contraindications of COVID-19 therapeutics training, training in the recognition and treatment of emergency reactions to COVID-19 therapeutics, and any additional training required in the United States Food and Drug Administration approval, authorization, or licensing;
|
|
(4) the pharmacy technician or student pharmacist
|
| must have a current certificate in basic cardiopulmonary resuscitation;
|
|
(5) the pharmacy technician or student pharmacist
|
| must comply with any applicable requirements or conditions of use that apply to the administration of COVID-19 therapeutics;
|
|
(6) the supervising pharmacist must comply with all
|
| relevant recordkeeping and reporting requirements;
|
|
(7) the supervising pharmacist must be readily and
|
| immediately available to the pharmacy technician or student pharmacist; and
|
|
(8) the registered pharmacy technician or student
|
| pharmacist and the supervising pharmacist must comply with all other requirements of this Act and the rules adopted thereunder pertaining to the administration of drugs.
|
|
(Source: P.A. 103-1, eff. 4-27-23; 103-593, eff. 6-7-24.)
|
